Literature DB >> 22276026

The role of funding and policies on innovation in cancer drug development.

P Kanavos1, R Sullivan, G Lewison, W Schurer, S Eckhouse, Z Vlachopioti.   

Abstract

Entities:  

Year:  2010        PMID： 22276026      PMCID： PMC3234026          DOI： 10.3332/ecancer.2010.164

Source DB:  PubMed          Journal:  Ecancermedicalscience        ISSN： 1754-6605


× No keyword cloud information.
  103 in total

1.  Do (more and better) drugs keep people out of hospitals?

Authors:  F R Lichtenberg
Journal:  Am Econ Rev       Date:  1996-05

Review 2.  Cell adhesion is a key determinant in de novo multidrug resistance (MDR): new targets for the prevention of acquired MDR.

Authors:  K H Shain; W S Dalton
Journal:  Mol Cancer Ther       Date:  2001-11       Impact factor: 6.261

3.  A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coley's mixed toxins, in which diagnosis was confirmed by microscopic examination selected for special study.

Authors:  H C NAUTS; G A FOWLER; F H BOGATKO
Journal:  Acta Med Scand Suppl       Date:  1953

Review 4.  The promise of cancer vaccines.

Authors:  Eli Gilboa
Journal:  Nat Rev Cancer       Date:  2004-05       Impact factor: 60.716

5.  Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry.

Authors:  J A DiMasi; R W Hansen; H G Grabowski; L Lasagna
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

Review 6.  DNA vaccines: precision tools for activating effective immunity against cancer.

Authors:  Jason Rice; Christian H Ottensmeier; Freda K Stevenson
Journal:  Nat Rev Cancer       Date:  2008-02       Impact factor: 60.716

7.  Facilitating patient-centered cancer research and a new era of drug discovery.

Authors:  John E Niederhuber
Journal:  Oncologist       Date:  2009-04-13

8.  Cancer research funding in Asia.

Authors:  Margaret Harris Cheng
Journal:  Mol Oncol       Date:  2007-09       Impact factor: 6.603

9.  Trends in the global funding and activity of cancer research.

Authors:  Seth Eckhouse; Grant Lewison; Richard Sullivan
Journal:  Mol Oncol       Date:  2008-03-27       Impact factor: 6.603

Review 10.  Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives.

Authors:  Steven Hirschfeld; Peter T C Ho; Malcolm Smith; Richard Pazdur
Journal:  J Clin Oncol       Date:  2003-02-07       Impact factor: 44.544
View more
  8 in total

Review 1.  Philanthropic partnerships and the future of cancer research.

Authors:  Yonina R Murciano-Goroff
Journal:  Nat Rev Cancer       Date:  2014-12-04       Impact factor: 60.716

2.  Statistical research on the bioactivity of new marine natural products discovered during the 28 years from 1985 to 2012.

Authors:  Yiwen Hu; Jiahui Chen; Guping Hu; Jianchen Yu; Xun Zhu; Yongcheng Lin; Shengping Chen; Jie Yuan
Journal:  Mar Drugs       Date:  2015-01-07       Impact factor: 5.118

Review 3.  Drugs, cancer and end-of-life care: a case study of pharmaceuticalization?

Authors:  Courtney Davis
Journal:  Soc Sci Med       Date:  2014-12-02       Impact factor: 4.634

4.  Gene function in schistosomes: recent advances toward a cure.

Authors:  Arnon D Jurberg; Paul J Brindley
Journal:  Front Genet       Date:  2015-04-15       Impact factor: 4.599

5.  The recent landscape of cancer research worldwide: a bibliometric and network analysis.

Authors:  Bernardo Pereira Cabral; Maria da Graça Derengowski Fonseca; Fabio Batista Mota
Journal:  Oncotarget       Date:  2018-07-17

6.  Towards Better Pharmaceutical Provision in Europe-Who Decides the Future?

Authors:  Denis Horgan; Tanja Spanic; Kathi Apostolidis; Giuseppe Curigliano; Joanna Chorostowska-Wynimko; Hans-Peter Dauben; Jonathan A Lal; Rafal Dziadziuszko; Christine Mayer-Nicolai; Marta Kozaric; Bengt Jönsson; Iñaki Gutierrez-Ibarluzea; Marie-Helene Fandel; Ruth Lopert
Journal:  Healthcare (Basel)       Date:  2022-08-22

7.  Position paper of the EPMA and EFLM: a global vision of the consolidated promotion of an integrative medical approach to advance health care.

Authors:  Olga Golubnitschaja; Ian D Watson; Elizabeta Topic; Sverre Sandberg; Maurizio Ferrari; Vincenzo Costigliola
Journal:  EPMA J       Date:  2013-05-10       Impact factor: 6.543

Review 8.  The political economics of cancer drug discovery and pricing.

Authors:  David G Taylor
Journal:  Drug Discov Today       Date:  2020-09-11       Impact factor: 7.851
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.